|
|
|
|
|
|
by throwGuardian
2283 days ago
|
|
|
1. Invest 50% in an index fund 2. For the short term gains, Gilead sciences, and other antiviral makers, even generic chloroquine & friends, are likely to gain FDA approval for CV. 3. Ventilator makers and even CPAP manufacturers are likely to see a massive spike in demand Donate your gains from #2, #3 to needy CV patients/health Care centres |
|
|